The global gastric motility disorder drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Gastric motility (or gastrointestinal motility) is the process by which food travels through the digestive tract through a series of muscular contractions called peristalsis. When someone has a gastric motility disorder, these contractions do not occur normally, and food is not able to pass through the intestines properly. These disorders are further responsible for a wide range of medical conditions such as gastroesophageal reflux disease (GERD), difficulty in swallowing, gastric problems, diarrhea or severe constipation, vomiting, abdominal pain, and bloating. Thus, in order to treat these wide range of medical conditions, the demand for gastric motility disorder drugs is likely to grow in the future years, thereby propelling the market growth.
To Request a Sample of our Report on Gastric Motility Disorder Drug Market: https://www.omrglobal.com/request-sample/gastric-motility-disorder-drug-market
- Adding to this, the prevalence of gastroparesis and irritable bowel syndrome (IBS) is also associated with the gastric motility disorder. The rising geriatric population which is more prone to gastrointestinal disorders, and the shifting focus of global population toward preventive health management are also anticipated to spur the global digestive health enzymes market. The secretion of digestive enzymes generally reduces with age, which is responsible for poor digestion, frequent gastric discomfort, reduced food consumption, and even various other gastrointestinal disorders. Other factors that are anticipated to boost the market growth include the efficiency of these drugs in treating various conditions such as pancreatitis, exocrine pancreatic insufficiency, and pancreatic cancer. Thus, the growing burden of these diseases call for an effective solution such as gastric motility disorder drug.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Eli Lilly and Co., and Theravance, Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Gastric Motility Disorder Drug Market is Available @ https://www.omrglobal.com/industry-reports/gastric-motility-disorder-drug-market
Global Gastric Motility Disorder Drug Market Report by Segment
By Type
- Velusetrag
- Ipamorelin
- TD-8954
- Others
By Application
- Hospital
- Clinic
- Home Use
Global Gastric Motility Disorder Drug Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
